LTR Pharma (ASX:LTP) partnered with pharmaceutical wholesaler Symbion to establish national distribution capabilities for Spontan, a nasal spray treatment for erectile dysfunction, according to a Wednesday filing with the Australian bourse.
Symbion will offer warehousing, inventory management, and nationwide distribution services for Spontan starting in March, the filing said.
The operational integration is scheduled for rollout in the second quarter, per the filing.
Shares were up 12% in midday trade Thursday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。